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SUMMARY

Genome-wide analysis of thymic lymphomas from
Tp53/ mice with wild-type or C-terminally truncated Rag2 revealed numerous off-target, RAGmediated DNA rearrangements. A significantly higher
fraction of these errors mutated known and suspected oncogenes/tumor suppressor genes than
did sporadic rearrangements (p < 0.0001). This tractable mouse model recapitulates recent findings
in human pre-B ALL and allows comparison of
wild-type and mutant RAG2. Recurrent, RAG-mediated deletions affected Notch1, Pten, Ikzf1, Jak1,
Phlda1, Trat1, and Agpat9. Rag2 truncation substantially increased the frequency of off-target V(D)J
recombination. The data suggest that interactions
between Rag2 and a specific chromatin modification, H3K4me3, support V(D)J recombination fidelity.
Oncogenic effects of off-target rearrangements
created by this highly regulated recombinase may
need to be considered in design of site-specific nucleases engineered for genome modification.
INTRODUCTION
Antigen receptor genes are assembled by controlled, large-scale
deletions and inversions (Little et al., 2015). Errors in this process, known as V(D)J recombination, produce aberrant genomic
rearrangements, which can fuel the development of T- and B-cell
malignancies (Onozawa and Aplan, 2012). Normal V(D)J recombination entails double-strand DNA cleavage at pairs of gene
segments by the heteromeric Rag1 and Rag2 endonuclease
(hereinafter referred to as RAG). RAG recognizes conserved

recombination signal sequences (RSSs) positioned adjacent to
coding segments that are subsequently joined to form immunoglobulin (Ig) and T-cell receptor (TCR) variable region exons (Figure 1A). Enzymatic steps in joining are carried out by general
DNA repair functions.
Mechanisms underlying aberrant V(D)J recombination
comprise three general categories according to outcome and/
or genetic dependencies. One is off-target cleavage (Figure 1B)
at sequences fortuitously resembling an RSS (i.e., a cryptic RSS,
or cRSS). A second type of mistake may occur at the point at
which DNA ends are joined (Figure 1C). A third involves interchromosomal (trans) recombination (Figure 1D). Such errors,
which can be compounded, leave distinctive traces in the structure of the junctions they produce in the genomes of lymphoid
neoplasms (Marculescu et al., 2006; Onozawa and Aplan,
2012). A stunning example of a V(D)J recombination gone wrong
was provided by recent genome-wide sequence analysis of pediatric acute lymphocytic leukemia (ALL), which revealed tumor
genomes peppered with structural rearrangements caused by
off-target V(D)J recombination (Papaemmanuil et al., 2014).
Studies in mice and in cultured cells indicate that multiple strategies direct RAG to appropriate loci in appropriate cells, but the
degree to which these also serve to prevent aberrant genomewide V(D)J recombination has not been determined. Possible
failsafes include regulation of Rag1 and Rag2 expression, attenuation of RAG activity during S-phase, chromatin features that
define possible recombination sites (transcription-associated
accessibility, locus contraction, histone H3 methylation, etc.), a
vigilant DNA damage response, and the RSS specificity of
RAG endonuclease itself (Little et al., 2015). Two features in
the Rag2 C-terminal domain have been explored at the molecular level. One is a specific phosphorylation site, targeted by cyclin
A/CDK2, that confines RAG activity to the G0/G1 phase of the
cell cycle. Another, also located in the C terminus, is a plant homeodomain-like domain (PHD) that specifically interacts with
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Figure 1. Normal and Aberrant V(D)J Recombination

(A) Normal V(D)J recombination. RAG binds
recombination signal sequence (RSS) motifs, meI. Target
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ble-strand breaks occur 50 of the RSS. Two coding
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ends (CE) lose and gain nucleotides in interim processing events and then join as a coding joint (CJ).
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contain junctional inserts (not diagrammed). GC23
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rich, ‘‘N regions,’’ are nucleotide additions that may
occur in either joint. Palindromic ‘‘P nucleotides’’
are found in CJs only.
trans join?
(B–D) V(D)J recombination errors. (B) A cRSS-like
element (cRSS; orange symbols) may join to an RSS
end-donation
hybrid joint
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or to a second cRSS. Off-target cleavage gives rise
to otherwise normal recombination products,
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yielding a cCJ and cSJ. (C) Alternatively, errors can
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occur at the joining stage. Coding and signal ends
may be swapped in error to form ‘‘hybrid joints’’.
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Alternatively, RAG-cleaved ends can be erronesignal joint (SJ)
cryptic signal joint (cSJ)
X
SE
trans SJ
ously connected to a third incidental break (enddonation; gapped red line). (D) Joining in trans
(between two chromosomes) is a third distinguishable type of aberration and can occur along with recognition or joining errors. ‘‘trans cut?’’ and ‘‘trans join?’’
reflect that trans events could occur at either stage. A reciprocal ‘‘type I’’ translocation is diagrammed (reviewed in Marculescu et al., 2006).
RSS:cRSS

cRSS:cRSS

RSS:RSS

RSS:RSS:X

H3K4me3, inducing a structural change in RAG that relieves a
negative autoregulation of its activity (Lu et al., 2015).
Engineered mouse models bearing mutant Rag2 alleles implicate the Rag2 C-terminal domain in curtailing the oncogenic
potential of V(D)J recombination. A T490A mutation at the phosphorylation site, as well as either partial (Rag2FS361 ) or complete
(Rag2352) deletion of the Rag2 C terminus (to amino acids 361
and 352s respectively), contributes to lymphomagenesis when
assayed in a p53-deficient background (Deriano et al., 2011;
Gigi et al., 2014; Zhang et al., 2011). Rag2T490A Rag2FS361 and
Rag2352, Tp53/ lymphomas exhibit chromosomal translocations cytogenetically mapping near Ig and TCR antigen receptor
loci (Deriano et al., 2011; Gigi et al., 2014; Zhang et al., 2011).
Such translocations are rarely, if ever, seen in lymphomas from
RAG2wt/wt Tp53/ mice (Deriano et al., 2011; Zhang et al.,
2011).
To investigate the role of Rag2’s C terminus in suppressing
oncogenic V(D)J recombination events, we analyzed structural
genome variations in lymphomas from either Rag2wt/wt,
Tp53/ or Rag2352/352, Tp53/ mice. The Rag2352 mutation
causes a significantly more rapid onset of lymphomagenesis
than any of the other aforementioned Rag2 mutations in the
Tp53/ background. This experimental model has several advantages over genome-wide characterizations of human tumors.
It is possible to collect independent tumors from animals of the
same genotype. Irrelevant ‘‘passenger’’ mutations are disfavored by the very short interval—within the first 14 weeks of
life—in which tumors arise. Mouse studies avoid potentially confounding effects of therapy, which can be very difficult to control
when examining human tumors. Additionally, there is a large
body of genome-wide information on chromatin modification,
Rag2 binding, and DNA accessibility as applied to purified subsets of primary developing T cells, a level of characterization not
yet available for humans.

RSS:RSS

Analysis of nine thymic lymphoma genomes yielded 275
validated somatic structural rearrangements. Most chromosome translocations near Ig and TCR loci lacked evidence of
V(D)J recombination error (Figure 1). Furthermore, the rearrangements showed no apparent connection to lymphomagenesis. In
contrast, there were numerous deletions arising from off-target
V(D)J recombination, many of which mutated genes with a
known or strongly supported role in oncogenesis. It was evident
that this type of aberrant V(D)J recombination is an inherent risk
of the antigen receptor gene rearrangement process being
observed in both Rag2352 as well as wild-type Rag2-expressing
mice. Results with the experimentally tractable model broadly
recapitulate observations in human B-ALL. Furthermore, the distribution of off-target breakpoints relative to histone H3K4me3differentiated chromatin suggests that a known Rag2-mediated
negative autoregulation of RAG activity deters the endonuclease
from generating oncogenic rearrangements.
RESULTS
Deletion Is the Predominant Structural Variant Class in
p53-Deficient Lymphomas
Through genome-wide analyses, we compared the somatic
structural variants (SVs) in T-cell lymphomas from Tp53/
mice to those from Rag2352/352, Tp53/ double mutants (Experimental Procedures; tumor phenotypes are given in Figures S1A
and S1B). Tumors were sequenced with an average coverage of
143. 57 somatic SVs (range = 8–20) were identified in four
Tp53/ lymphomas, and 218 SVs (range = 23–68) were detected in five Rag2352/352, Tp53/ lymphomas (Figure 2). Breakpoints mapped to scattered positions throughout the genome
(Figure 2). Over half of the junctions were deletions, the remaining being divided among inversions, translocations, and
apparent duplications (Figure S1D).
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Figure 2. Structural Alterations in Thymic
Lymphoma Genomes
Circos plot representation of all rearrangements
(including normal Ig/TCR junctions) detected in
the genome-wide analyses. Ig and TCR loci are
marked by symbols. Translocations (seen as arcs)
are more prevalent and show a tendency to localize
in the region of Ig/TCR genes in Rag2352/352,
Tp53/ tumors.
See also Figures S1 and S4.

Normal and Abnormal Rearrangements at TCR
and Ig Loci
Among the 275 validated somatic rearrangements, 76
authentic V(D)J junctions were recovered (Figure S1; Table
S1). Some junctions were supported by as few as two paired
reads, confirming the high sensitivity of our analysis pipeline
(Figure S1; Table S2). About 15% of the Ig or TCR locus recombinants were composed of abnormal J-to-J junctions;
junctions between V gene segments and ‘‘locus-deleting elements’’; incomplete (out-of-order) V-D recombination; directly
joined Vd-to-Jd junctions (skipping D); and, in the case of the
only detected signal joint, an atypical loss of sequence from
the RSS of both signal ends (Table S1). Each type of abnormality is documented in wild-type, untransformed thymocytes.
Rearrangements involving authentic V(D)J gene segments provided an internal control for various comparisons made in this
study.
Off-Target V(D)J Recombination
To date, available systematic methods for identifying cRSS
either are of unproved accuracy or use an algorithm of limited
availability; nonetheless, an ability to identify (and quantify) offtarget V(D)J recombination errors is a key necessity for the
present study. We formulated and tested two simple criteria.
First, a CAC must exist to the right (or GTG to the left) of both
breakpoints (a point addressed more fully later), and, second,
it must occur within a specified distance from the breakpoint.
The conserved CAC of an RSS heptamer demarcates the position at which RAG makes its cut, and the distance between the
CAC motif and a breakpoint reflects the limited number of
base pairs that may be lost when an end is processed prior to
ligation. For coding joints, the CAC distance-to-breakpoint value
was set at 21 bp, the maximum observed for authentic RSS junctions in the data (Figure 3A). When each is plotted according to
their two distance-to-breakpoint values, authentic V(D)J junctions fell into a tight cluster averaging 3 nt from either CAC motif.

When the remaining 198 SVs from our
dataset were similarly plotted, two
distinct distributions emerged: junctions
with CAC distance-to-breakpoint values
like authentic recombination products
and those with a wider, randomly distributed set of distances. The presence of
two populations in our experimental data
was confirmed by analyzing a set of
180 simulated junctions (see the Supplemental Experimental Procedures), which reconstructed only
the broadly scattered distribution (Figure 3A).
Sequence logos (Crooks et al., 2004) were used to visually
compare (1) the RSSs targeted in Ig and TCR junctions, (2) the
cRSSs of cryptic junctions identified according to the CAC-tobreakpoint value, (3) the analogous ‘‘nonRSSs’’ of all junctions
falling outside the 21-bp CAC-to-breakpoint range, and (4) the
identically defined ‘‘simRSSs’’ of the simulated junction set (Figure 3B). Authentic targeted RSS elements gave the best match to
the canonical RSS (CACAGTG [12/23 spacer] ACAAAAACC),
most consistently at functionally important positions (Little
et al., 2015). Similarly, the consensus sequence of the presumptive cRSSs reconstructed the canonical RSS except for the last
two (CC) of the nonamer. There was a strong signal for the heptamer sequence beyond CAC and a signal at the functionally
important nonamer positions 5, 6, and 7 (Little et al., 2015).
The logos of the nonRSS and simRSS groups lacked these significant features.
A second test of the CAC distance-to-breakpoint method
evaluates the cRSS junction group for two hallmark features of
V(D)J recombination. These are ‘‘N regions,’’ short G/C-rich
insertions generated by terminal deoxynucleotidyl transferase
and palindromic (P) nucleotides. These arise when hairpin-terminated RAG cleavage intermediates are nicked a few base
pairs from the terminus and the opened ends happen to escape
trimming before becoming joined. In both respects, cRSS
junctions compared very well to the authentic V(D)J junctions
(Figure 3C). In contrast, the insertions seen in nonRSS junctions
were AT rich and more variable in size. P nucleotides were identified at the same frequency among cRSS as authentic V(D)J
junctions, while almost no qualifying inserts were seen in the
nonRSS group. These data indicate that the CAC distance-tobreakpoint criteria, indeed, identify off-target V(D)J recombination products.
The CAC distance-to-breakpoint method was largely in agreement with the computational approach (Papaemmanuil et al.,
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Figure 3. Application of a ‘‘CAC-Distance-to-Breakpoint’’ Method to Identify Off-Target, RAG-Mediated ‘‘Coding Joint-like’’ Junctions
(A) CAC-distance-to-breakpoint values distinguish two populations of junctions in T-cell lymphomas. Left: tumor V(D)J coding joints are plotted according to CAC
distance-to-breakpoint values. Middle: a plot of CAC distance-to-breakpoint values for all junctions other than authentic V(D)J coding joints shows a clustered
and dispersed pattern. Right: a CAC-distance-to-breakpoint plot for a set of simulated junctions. The boxed area in each panel indicates the 21-bp cutoff used to
discriminate between cRSS and nonRSS junctions as tested in (B) and (C). Numbers at the top refer to the number of junctions plotted within each set (junctions
with distance to breakpoint values exceeding 100 bp on one or both sides are not shown). The 74 RSS-to-RSS junctions represent all the coding joints generated
by V(D)J recombination, excluding1 hybrid joint and 1 signal joint. The ‘‘all except RSS-to-RSS junctions’’ set includes all other junctions (275 total junctions minus
74 coding joints, 1 hybrid joint, and 1 signal joint).
(B) The CAC-distance-to-breakpoint method identifies junctions with and without extended matches to the canonical RSS sequence. Top: V(D)J junctions in
tumors, as seen in (A), left panel, occur near RSS motifs that, as expected, exhibit canonical heptamer/nonamer sequences. The group of provisionally identified
cRSS junctions, shown in the red boxed area in the middle panel of (A), reveals a consensus sequence that matches 11 of 13 canonical heptamer and nonamer
positions. Putative cRSSs from nonRSS and simulated junctions (outside the red boxed area, including those not shown) do not resemble a canonical RSS. Some
bias toward nonamer matches is introduced by the method of nonamer assignment (Supplemental Experimental Procedures) but would not artifactually enhance
identities at functionally important positions. The CAC defining the heptamer start in all categories is shown for clarity, not for purposes of comparison.
(C) cRSS junctions as defined by the CAC-distance-to-breakpoint method have other, independent properties in common with V(D)J junctions. Junctional
insertions are seen in RSS, cRSS, and nonRSS junctions. cRSS junction inserts have restricted length and high G:C composition, as well as P nucleotides, a
unique feature of V(D)J recombination—similar to inserts observed in RSS junctions. Inserts in nonRSS junctions do not recapitulate these properties. Values in
parentheses exclude an extreme outlier: length exceeding Q3cRSS + ([MAXRSS  Q3RSS]yIQRRSS) , IQRcRSS. IQR, interquartile range.
See also Supplemental Experimental Procedures.

2014). In their study, 44 junctions were assigned with high confidence to off-target V(D)J recombination, 39 of which were also
identified by our criteria (Table S3). For 214 junctions that were
determined not to be cRSS related in the same study, there
was agreement on 185—again, a good concordance (86%).

The cryptic junctions detected by the distance-to-breakpoint
method in the nonRSS group appear to be properly assigned
because the sequence logo was well matched to the canonical
nonamer sequence. The third cRSS discovery method, based
on RIC (recombination information content) scores (Cowell
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Figure 4. Recurrent cRSS-Mediated Deletions

A

(A) Notch1 activation via cRSS-mediated
recombination. Top: diagram of the Notch1
protein indicating relevant domains. Middle:
representation of the Notch1 locus with lines
locating the corresponding translated regions in
the protein diagram. Triangles indicate cRSSs
identified in the present study as well as candidate cRSSs reported by Tsuji et al. (2004) (see
Supplemental Experimental Procedures for inB
clusion details). The most commonly observed
deletion removes the 50 promoter (blue arrow),
causing an internal promoter to be used (red
arrow). The resulting protein lacks the extracellular epidermal growth factor 1 (EGF1)-like
repeats, and the negative regulatory region
(NRR) but retains most of the transmembrane
(TM) domain. The truncated form is thought to
insert into the membrane and become cleaved
in a ligand-independent fashion, releasing
constitutively activated, intracellular Notch1
(ICN). All other Notch1 deletions likewise deleted
the 50 promoter. See Table S2 for junction sequences.
C
(B) Internal Jak1 deletions suggest another
instance of oncogene activation through cRSSmediated recombination. A diagram of domains
within the Jak1 protein is displayed above a
representation of the locus. Individual cRSSmediated deletions are shown as horizontal
arrows. cRSS coordinates (corresponding to
the heptamer border, mm9 genome assembly)
are given for each deletion. All parts of the diagram in red indicate the most frequent cRSS
deletion in Jak1. Clustering of the deletions
suggests that deletions in this region may be
activating (see Discussion; for sequences, see
Figure S2).
(C) Predicted reciprocal cryptic signal joints can be
detected in tumor DNA samples by PCR. Sequences of independently isolated cryptic signal joints from recurrent Jak1, Agpat9, and Trat1 rearrangements.
For evidence of ongoing recombination in thymoma, see Figure 3.
See also Supplemental Experimental Procedures, Figures S2 and S4, and Table S2.

et al., 2001), did not perform as robustly. Only 12 (31%) of the
39 concordant junctions—i.e., off-target V(D)J recombination
products with strong support—bore a cRSS at both breakpoints
according to RIC scores, and, individually, over half of the 39
cRSSs failed the RIC test (Table S3). Overall, our test and that
of Papaemmanuil et al. (2014) appear equally discriminatory,
given that the percent coincidence for both positive and negative
assignments is about the same.
We note, however, that because the sensitivity of our method
is based on the presence of a cRSS on both sides of the junction,
it is not suited to the detection of ‘‘one-sided’’ events (which
are predicted for end-donation errors; Figure 1B). Nevertheless,
we found no evidence that end-donations could constitute
more than a minor fraction of aberrant V(D)J recombination products. End-donations suffering extensive resection after cleavage
would not have been detected by our analysis. Moreover, many
one-sided junctions in the collection of Papaemmanuil et al.
(2014) qualified as two-sided products according to the CAC distance-to-breakpoint test (Table S3).

Off-Target V(D)J Recombination Causes Recurrent
Deletions in Notch1 and Jak1
Mutations causing constitutive activation of the Notch1 oncogene have been demonstrated in both human and mouse
T-cell neoplasms. In the latter, recurrent cRSS-mediated deletions are found that produce a Notch1 protein activated via
N-terminal truncation (Ashworth et al., 2010; Jeannet et al.,
2010; Van Vlierberghe and Ferrando, 2012). The two most
commonly observed Notch1 deletions (Tsuji et al., 2004) were
also seen in our dataset, along with additional examples (Figure 4A; Figure S2). Our results, along with data from Tsuji et al.
(2004), identify 14 functional cRSSs in a 30-kb span of the
Notch1 locus (Figure 4A). This high density of functional cRSSs
agrees with predictions based on artificial recombination substrates (Lewis et al., 1997).
PCR primers specific for each Notch1 cRSS defined in the
present study were used to assay for additional deletions that,
due to coverage, may not have been detected in the genomewide analysis. These were indeed seen, giving a total of eight
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Figure 5. Recurrently Disrupted Genes and
Cancer-Associated Genes Are Found in
Tumors of Both Genotypes
Genes mutated in tumors from different mice are
listed above the thick line. The tumor harboring
the detected mutations is indicated at the top of
each column. Check marks and other symbols
are defined in the key. There were no clustered,
recurrent breakpoints shared between tumors
occurring outside a gene. A comprehensive list of
cancer gene mutations, whether multiply or singly
observed in this study is given. Yellow boxes indicate genes that occur among the 572 currently
listed in the COSMIC Cancer Gene Census (http://
cancer.sanger.ac.uk/census). Green boxes indicate genes with a likely cancer association. wt,
wild-type.
See also Table S4.

Notch1 deletions. They recur in independent tumors, involve multiple sets of
cRSSs, overlap one another over a specific area of the locus, and may provide
for production of a modified (rather than
absent) protein product. The similarities
raise the possibility that, as for Notch1,
these cRSS-mediated mutations might
activate Jak1.

distinct Notch1 deletions (Figure S2), distributed between all
five RAG2352/352, Tp53/ tumors and two of the Tp53/-only
isolates (Figure 5). All deletions encompassed the 50 region of
the gene, deleting the 50 promoter, as is the case for cRSSmediated mutations previously demonstrated to result in constitutive Notch1 activation (Ashworth et al., 2010; Jeannet et al.,
2010).
We also identified recurrent, cRSS-mediated rearrangements at a second known oncogene, Jak1. One specific
recurrent deletion (8.2 kb) eliminated exons 6 through 8 (Figure 4B; Figure S2) and was found in every Rag2352/352 thymic
lymphoma, as well as in one Rag2w/wt tumor, by PCR. These
Jak1 deletions share several properties with the activating

cRSS-Mediated Deletions and
Candidate Driver Mutations
cRSS junctions affected genes with a
potential oncogenic impact in that they
govern cell proliferation, differentiation,
or survival. Of these, 21 specific deletions
were selected for PCR analysis in the
hope of discovering additional recurrently mutated genes. We examined the
nine original tumors and six additional
Rag2352/352 p53/ tumors, revealing
recurrent, cRSS-mediated deletions at
three more loci: Trat1, Phlda1, and
Agpat9 (Figure S2). All recurrent mutations, except the Phlda1 deletion, were
verified in both Tp53/, RAG2352/352
/
and Tp53 -only lymphomas (Figure 5). Recurring examples
of the same cRSS junction in independent tumors suggest the
possibility that, as in Notch1, these specific gene disruptions
are driver mutations.
If off-target V(D)J recombination is a force in the oncogenic
process, it should be possible to detect enrichment of cRSS
junctions among SVs that interrupt genes of significance in
cancer. ‘‘Cancer genes’’ were defined by a metric based on
the co-occurrence of search terms in the Web of Science Core
Collection (http://apps.webofknowledge.com/) (Experimental
Procedures; Table S4). Almost 90% of cRSS junctions in the
collection interrupted a gene, and well over half of these genes
(65%) were associated with cancer (for additional details, see
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Figure 6. Overview and Role of Off-Target
V(D)J Recombination

A

(A) SVs generated by either RSS, cRSS or nonRSS
mechanisms in RAG2352 versus RAG2wt tumors.
Off-target V(D)J joints (cRSS-cRSS and cRSSRSS), on-target RSS-RSS V(D)J, and non-RSS
junctions are indicated by colors given in the key.
cRSS-mediated events account for 46% of the
structural genomic alterations in the RAG2352/352,
Tp53/ tumors, but this is the case for only 15%
of rearrangements in cRSS-mediated in thymic
tumors.
(B) The role of cRSS recombination in tumor formation. The y axis in each plot represents junction
numbers. Black, stippled, and white sections
indicate junctions in cancer genes, non-cancer
(Other) genes, and non-genes, respectively, for all
junctions except those involving an RSS (RSS-RSS
and RSS-cRSS). Assignment of cancer gene
association is given in Table S4. There is a highly
significant difference between cRSS versus
nonRSS mechanisms with respect to observed
mutations in cancer-associated genes (p <
0.0001). A further breakdown of the data in (B),
right panels, represents the impact of the Rag2
C terminus RAG2 carboxyl-terminal domain
with respect to three types of rearrangements.
RAG2352/352 tumors show a bias toward cRSSmediated cancer gene mutations relative to nonRSS mechanisms that is absent in RAG2 wild-type
(WT) tumors (compare the four black sections in
each of the four bars, right panel; the p value for the
difference is 0.0044).
See Tables S4 and S5.

B

Supplemental Experimental Procedures;,Table S4). By comparison, 70% of nonRSS junctions had breakpoints located within a
gene, and only 24% of these disrupted cancer genes, a highly
significant difference (p < 0.0001; Table S5). These data, summarized in Figure 6, support the possibility that off-target V(D)J
recombination contributes to oncogenesis.
To investigate whether the Rag2 C terminus reduces oncogenic mutation, the degree to which cRSS versus nonRSS junctions interrupt cancer genes was further compared between
Tp53/, RAG2352/352 and Tp53/-only tumors. The fraction of
cancer genes that were ‘‘hit’’ by cRSS recombination with
Rag2352 was significantly different than that observed with intact
Rag2 (p = 0.0044; Figure 6B; Table S5C).
Excision Products Containing cRSS Signal Joints
Indicate Recent Recombination Activity
V(D)J recombination co-generates reciprocal products, a coding joint, and a signal joint. When a coding joint is created by
deletion, the signal joint will occur on an excised circular DNA
molecule (Fujimoto and Yamagishi, 1987) (Figure 1A). The cir-

cular excision products, dubbed ‘‘Trecs’’
(TCR rearrangement excision circles)
do not replicate and are progressively
diluted by cell division. We sought evidence that cryptic Trecs (cTrecs) might
be generated by off-target recombination. To maximize the possibility of detection, we focused the
effort on recurrent cRSS rearrangements. Excised signal joints
reciprocal to the Jak1, Phlda, and Trat1 cryptic coding joints
were recovered by PCR (Figure 4C).The demonstration of
cTrecs corresponding to chromosomal cRSS rearrangement
is a new observation. By analogy to Trecs, it appears that
off-target V(D)J rearrangements occurred relatively recently in
the history of the rapidly dividing tumor, indicating ongoing
recombination activity. (Identification of cTrecs corresponding
to potential oncogenic events does not, however, mean that
they are related to founder mutations; rather, it reflects the
evolving, multiclonal nature of the lymphomas, as noted in
the Discussion.) Consistent with this possibility, RAG transcripts were detected in several tumors (Figure S3). Furthermore, a high level of V(D)J recombination was detected with
a standard extrachromosomal recombination assay in a cell
line established from a Rag2352/352, Tp53/ tumor (Figure S3).
The presence of specific cTrecs could conceivably provide an
additional parameter for phenotyping human tumors as well
as be an indicator of recent mutation.
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Figure 7. Truncation of the Rag2 C Terminus
Disrupts a Correlation between cRSS
Breakpoints and H3K4me3
(A) Distribution of breakpoints (blue, yellow, and
green indicate RSS, cRSS, and nonRSS, respectively) relative to published genome-wide determinations of DNase I hotspots (left), H3K4me3
chromatin immunoprecipitation sequencing (ChIPseq) analysis of a genetically isolated DP thymocyte population (middle), and RAG2 ChIP-seq
analysis, same population (right). Bar heights
represent the percentage of breakpoints in DNase I
hotspots, tri-methylated H3K4 peaks, or RAG2
binding peaks. Correlations between breakpoint
categories and chromatin features are significantly
different from a random distribution as indicated
for the evaluated RSS and cRSSs. The correlation
between nonRSS breakpoints and DNase I hotspots reached significance, but nonRSS breakpoints were not markedly different from random
with respect to H3K4me3 or RAG2 binding peaks.
(B) Comparisons made between breakpoints in
p53 null tumors with wild-type (WT; solid bars)
versus C-terminally truncated RAG2. Left: blue
bar graphs give the percentage of authentic
RSS breakpoints co-localized with accessibility,
H3K4me3 modification, and RAG binding. No
statistically significant differences are seen between genotypes. Right: orange bars indicate the
percentage of cRSS breakpoints co-localized with
accessibility, H3K4me3 modification, and Rag2
binding. The cRSS breakpoints have a significantly
reduced coincidence with H3K4me3 in RAG2352
tumors when compared to the cRSS breakpoints
in RAG2wt tumors (two-tailed Fisher’s exact test).
None of the other comparisons reach significance.
See also Table S5.

Chromosomal cRSS Signal Joints Are Surprisingly Rare
If, as expected, cRSS targets are randomly oriented with respect
to one another in the genome, recombination between any pair
of cRSSs should be as likely to generate a signal joint as a coding
joint. Rearrangement of a pair of cRSSs that happen to be oriented ‘‘heptamer to heptamer’’ produces a cryptic signal joint
that remains in the chromosome. Surprisingly, chromosomal
coding joints outnumbered chromosomal signal joints 6- to
7-fold in the tumor genomes (Tables S1 and S3). A marked deficit
was also seen in data from human ETV6-Runx1 ALL (Papaemmanuil et al., 2014): we found only one cryptic signal joint among
140 candidate junctions (Table S3). Indeed, very few signal joints
representing off-target V(D)J recombination products have been
reported thus far (e.g., Mendes et al., 2014). The rarity of cryptic
signal joints in the tumor genomes is not due to a failure in their
production, because as described earlier, cTrecs are found
corresponding to Trat1, Agpat9, and Jak1 rearrangements. It is
not obvious what the chromosomal cSJ deficit means, but the
consistency with which it is observed suggests that further
investigation could be revealing.
Genomic Context of Functional cRSSs
Our data establish firmly that off-target V(D)J recombination occurs in tumors bearing wild-type RAG1 and RAG2, underscoring
the importance of mechanisms that counteract recognition

errors during V(D)J rearrangements. Such errors might be minimized by chromatin/RAG interactions. Three relevant chromatin
properties have been measured at the whole-genome level in
primary mouse cell populations corresponding to CD4+ CD8+
T-cell precursors or to unfractionated thymocytes (most of which
are CD4+ CD8+ pre-T cells). The properties measure accessibility, as reflected by DNase I sensitivity (Sabo et al., 2006),
methylation of lysine 4 in histone H3 (Ji et al., 2010; Vigano
et al., 2014), and the location of chromatin-bound Rag2 (Ji
et al., 2010).
The location of each 39-bp interval (a length that accommodates both 12- and 23-bp versions of a RAG target) corresponding to 162 RSSs, 163 cRSSs, and 224 nonRSSs (Table S6) in the
thymic tumors was determined. The relationship of the target
motif and the position of H3K4me3-modified chromatin is not
known, so this choice minimized imprecision introduced by taking a larger interval to both sides of the breakpoint. The percentages of RSS targets overlapping DNase I-sensitivity hotspots,
H3K4me3-modified chromatin, or Rag2-binding regions are
shown in Figure 7B. Even in the case of authentic RSSs, slightly
over half lay in chromatin bearing all three features, and 14% of
RSS breakpoints occupied positions that lacked any of the
properties. This is likely due to the fact that the distribution of
marks is measured in aggregate and, thus, may not reflect minor
subpopulations. Similarly, the degree to which these aggregate
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measurements reflect the situation in a tumor cell at the time of
cRSS rearrangement cannot be determined.
Despite these caveats, cRSS breakpoints exhibited a nonrandom distribution relative to DNase I hotspots, H3K4me3modified chromatin, and RAG2 binding (p < 0.0001; Table
S5E). Localization of cRSS breakpoints to the aforementioned
markers may define the state of genomic regions susceptible
to off-target V(D)J recombination. Alternatively, considering
that all three properties, including Rag2 binding (Ji et al., 2010),
are directly or indirectly associated with active gene expression,
a more trivial possibility is that the distribution of cRSS targets
nonspecifically reflects DNA target accessibility.
Because Rag2352 lacks the PHD domain implicated in recognition of H3K4me3 marks, the location of breakpoints in relation to
this chromatin mark was further examined. Comparing cRSS
sites in wild-type Rag2, Tp53/ tumors with those in arising in
Rag2352/352, Tp53/ revealed no significant differences with respect
to colocalization of authentic RSS targets and H3K4me3 (Figure 7).
In contrast, the distribution of cRSS targets with respect to
H3K4me3 was significantly different (p = 0.0007). Thus, C-terminally truncated RAG2 appears markedly less constrained by the
presence of H3K4me3 than its wild-type counterpart.
Most Translocation Junctions Reveal No Apparent Link
to V(D)J Recombination
In 22 translocation SVs, we detected 23 translocation junctions
(one SV contained two junctions). Genome-wide SV analysis
confirmed earlier findings that translocations with breakpoints
near TCR loci were present in Rag2352/352, Tp53/ lymphomas
and not the Tp53/-only counterparts (Deriano et al., 2011) (Figure 2). Between the two BAC probes used in our previous study
(Deriano et al., 2011) we identified a total of five junctions in two
RAG2352/352, Tp53/ tumors (#132 and #12165). Of these, only
one can be, without a doubt, classified as an off-target V(D)J rearrangement. This is the translocation between chr4 and chr14,
creating a signal joint composed of the RSS of a TCR Va gene
segment (chr14) and a cRSS within a Kdm1a locus (chr4) (Figure S4). In the case of a simple trans joining error, a coding joint
should be present on a reciprocal derivative chromosome, and
this was, indeed, demonstrated by PCR of the tumor DNA (Figure S4). The 4:14 exchange illustrated that trans joining errors
likely play a role in tumor formation, because there is abundant
evidence that mutation of Kdm1a, a histone deacetylase gene,
is significant in leukemia (Harris et al., 2012). This was in contrast
to the other translocations, of which none interrupted a cancerassociated gene (Table S4). Furthermore, we found no evidence
of RSS or cRSS in these junctions, suggesting that another
mechanism is responsible. These results raise the question of
whether apparent locus-specific structural rearrangements in
other Tp53/ mouse models can be attributed to V(D)J recombination, as few recombinant junctions have been analyzed at
the DNA sequence level.
DISCUSSION
The genomic lesions described here bear striking similarities to
those recently reported in pediatric ETV6-Runx1 B-ALL (Papaemmanuil et al., 2014). Common to both is a preponderance

of deletions, many resulting from off-target V(D)J recombination.
In both cases, RAG-mediated deletions between pairs of cRSSs
create known and suspected driver mutations. trans events
involving V(D)J recombination are much less frequent, and in
both studies, misrecognition of RSSs is seen to occur in tumors
with wild-type RAG. In human ETV6-Runx1 B-ALL, initiating
events are thought to occur prenatally, but tumors were not
available for investigation until they reached, on average,
57 months of age (Papaemmanuil et al., 2014). By comparison,
Rag2352/352, Tp53 null mice die of thymic lymphomas at a median
age of 13 weeks. The status of the genome in the murine system
provides as close a reflection of the ‘‘smoking guns’’ in the oncogenic process as is currently possible.
The paucity of chromosome translocations involving antigen
receptor loci in our dataset is striking, given our previous
identification of such translocations in thymic lymphomas
from Rag2352/352, Tp53 null mice (Deriano et al., 2011). This
discrepancy likely arises because the translocations detected
by cytogenetic techniques in our earlier work, while recurrent,
were not uniformly present in all tumors and, in many cases,
were present in minor subpopulations (Deriano et al., 2011; see
Table S1). Thus, those translocations—which, based on their frequency, are unlikely to represent driver mutations—might not
have been present in the tumor samples analyzed here or were
at a low enough abundance to have escaped detection by
whole-genome sequencing.
Rag2 C Terminus-H3K4me3 Interactions May Enhance
the Fidelity of V(D)J Recombination
Comparison of genomic lesions in lymphomas from Rag2wt/wt,
Tp53/ and Rag2352/352, Tp53/ mice revealed that, although
off-target V(D)J recombination events are found in both genotypes, they are much more prevalent when Rag2 is C-terminally
truncated. cRSSs identified in Rag2352/352, Tp53/ tumors occur
significantly more frequently outside H3K4me3-modified regions
of the genome (as measured in normal pre-T cells) (Ji et al., 2010;
Vigano et al., 2014) than those in Tp53/ mice. The significance
of this bias is underscored by the fact that comparisons of a less
specific ‘‘accessibility’’ (DNase I sensitivity and Rag2 binding)
show inconsistent trends between genotypes and fail to reach
statistical significance. These data establish a mechanistic link
between the PHD domain located in RAG2’s C terminus,
H3K4me3-modified chromatin, and suppression of off-target
V(D)J recombination. The possibility of such a link has been
suggested most recently in a biochemical study showing that
RAG autoinhibition was relieved when the PHD finger of the
Rag2 C terminus was allowed to interact with H3K4me3 peptides
(Lu et al., 2015). The observations reported here support a role
for H3K4me3-mediated reversal of autoinhibition in minimizing
the oncogenic impact of faulty RSS recognition.
Numerous Rearrangements Lacking Identifiable
Features of V(D)J Recombination Junctions in
Rag2352/352 Rumors
Curiously, all classes of SV, whether arising from authentic V(D)J
recombination, cRSS rearrangement, or apparently nonRSSmediated accidents (sporadic deletions, inversions, and duplications included) were quantitatively increased in Rag2352/352,
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Tp53/ tumors. We considered several possible explanations
for this observation. An overall increase in SVs might be caused
by the loss of the T490 phosphorylation site. Rag-mediated
breaks arising inappropriately during S phase could induce
DNA repair functions that are error prone when handling other
types of damage. Also, if coding ends bearing unresolved hairpin
termini are abnormally available during S phase, they may be
replicated, resulting in the generation of DNA palindromes.
Such sequences are very labile and are known to provoke
large-scale rearrangements in mice, humans, and yeast (Coté
and Lewis, 2008). Another possible explanation for an increase
in apparently non-specific sporadic junctions is that these may
actually arise from some yet-unrecognized form of aberrant
V(D)J recombination. For example, if uncontrolled, extensive
resection of cleaved ends is possible (on a kilobase-to-megabase scale), this would obliterate any signature of off-target
RAG cleavage in any resulting junction.
Off-Target V(D)J Recombination Generates Known and
Candidate Driver Mutations
Where mutation is repeatedly discovered in the same gene in independent tumors, it is usually taken as evidence of biological
selection in the pathological process. If, however, V(D)J recombination is the mutation mechanism, a relationship is less certain.
The repeated observation of a cryptic junction could be due to
properties that fortuitously favor recombination rather than biological selection. Whereas there is little question that Notch1,
Jak1, Ikzf1, Fhit, and Pten—all included in the short, expertly
curated list of 572 genes in the COSMIC Cancer Gene Census
(http://cancer.sanger.ac.uk/census/)—are drivers in the oncogenic process, the four remaining recurrently mutated genes
(Nr3c1, Trat1, Phlda1, and Agpat9) occupy a gray zone.
To address this, we developed a system for stratifying all the
genes mutated in the present study according to cancer relevance
(Experimental Procedures; Table S4). By this approach, Nr3c1
and Phlda1 belong to the same group as the aforementioned
genes and can also be considered cancer associated. Agpat9
(Table S4B) and Trat1, however, have modest or no support for
a cancer role in the literature (Table S4C). Although Agpat9 and
Trat1 are low-rated cRSS rearrangements, it may be significant
that both operate in pathways that are connected to oncogenesis.
Trat1 (TCR-associated protein 1) is upstream in the generation of
PIP3, which has regulatory interactions with both Akt1 and Pten.
The Pten pathway is evidently an Achilles heel, given that Pten itself is recurrently mutated by cRSS mechanisms here (Figure 1)
and in human T-ALL (Mendes et al., 2014). Agpat9 is a 1-acylglycerol-3-phosphate o-acyltransferase involved in the production of
phosphatidic acid, a cofactor in the AKT1/Tor pathway (Agarwal,
2012). It remains to be seen whether cRSS-mediated deletions
pinpoint new cancer genes, but given the potential applications,
this question bears further investigation.
Potential Mechanism for Jak1 Activation
Analyzing off-target mutations may enhance understanding of
cancer development mechanisms. It has been demonstrated
that cRSS rearrangements at Notch1 cause the production of
a truncated, activating form of the protein (Ashworth et al.,
2010; Jeannet et al., 2010). It would appear, given the number

of similarities between the two, that the Jak1 mutations seen
here, like the deletions at Notch1, may be activating. Activated
Jak1, caused by point mutations or other small changes that
increase protein stability, is seen in both human and murine
lymphoid tumors (Chen et al., 2012; Bellanger et al., 2014; Flex
et al., 2008). The commonly observed 8.2-kb cRSS-mediated
deletion here is compatible with the possibility of an in-frame
splice between exons 5 and 9 in the mRNA. This would delete
a large part of the FERM domain (Figure 4), eliminating functions
thought, at present, to be a prerequisite for mediating the oncogenic effects of Jak1 activation.
Are RAG-Mediated Off-Target Events Relevant to
Nuclease-Mediated Genome Editing?
Suppressing off-target cleavage is an exceptionally challenging
problem in the V(D)J recombination system and, as such, may
inform strategies for increasing the accuracy of genome editing
in clinical applications. During V(D)J recombination, several
layers of regulation converge to limit RAG action at inappropriate
target sites. Such measures include the tempo with which T-cell
intermediates traverse the vulnerable developmental stage
(Haines et al., 2006), the destruction of Rag2 upon entry into
S phase of the cell cycle, and the physical accessibility of the
underlying cRSS sequences upon transcription, histone modification, and chromatin looping (Little et al., 2015). Additionally,
highlighted here is the possible importance of chromatinmodulated Rag2 auto-inhibition in the suppression of off-target
activity. Finally, it goes without saying that a highly important
requirement for fidelity is an intact p53 pathway. These safety
nets, the product of millions of years of evolution, counteract
the potential for disaster inherent in a process that occurs in cells
with high proliferative ability throughout life. In the short term, it
may not be a simple task to computationally predict the unintended targets of manmade genome editing nucleases or to
reduce their numbers to a safe level by engineering ever more
stringent enzymes. The strategies used in the V(D)J recombination system may inform these efforts.
EXPERIMENTAL PROCEDURES
Mouse husbandry and experimentation were reviewed and approved by the
University of Pennsylvania Institutional Animal Care and Uses Committee.
Whole-genome tumor and normal paired-end libraries were sequenced and
 et al., 2012). Candidate
analyzed with a custom analysis pipeline (Mijuskovic
SVs that passed all filters were tested for tumor specificity by PCR (Table
S2). The DNA sequence of all 275 confirmed junctions was then determined
by Sanger sequencing. Detailed methods, including downstream analysis,
identification of cRSS junctions, creation of arbitrary junctions, and stratification of cancer genes, are presented in the Supplemental Experimental
Procedures.
Analysis of the genomic context of breakpoints in Figure 7 was
based on publicly accessible genome-wide DNase I hypersensitivity data
(wgEncodeUwDgfThymusC57bl6MAdult8wksHotspotsRep1),
H3K4me3
peaks (GSM530317), and RAG2 binding peaks (GSM530316) (Ji et al., 2010;
Sabo et al., 2006).
To visually confirm overlaps relative to H3K4me3 peaks (Ji et al., 2010), the
track was uploaded to the University of California, Santa Cruz (UCSC) browser
along with WIG (wiggle track format) files of genome-wide data from early
T-cell precursors (Vigano et al., 2014) (GSM1164638, GSM1164639,
GSM1164643, and GSM1164644). There was close agreement at the monitored breakpoints, despite the use of different cell purification methods and
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